Potential role of ATM in hepatocyte endocytosis of ApoE-deficient, ApoB48-containing lipoprotein in ApoE-deficient mice

International Journal of Molecular Medicine

Volumn 33, Issue 2, 2014, Pages 462-468

  Wu, Jianhua ^a   Xiao, Yanhong ^a   Liu, Juang ^a   Yang, Hong ^b   Dong, Xiaomin ^a   Hu, San ^a   Jin, Shanrui ^a   Wu, Dongfang ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

Ataxia telangiectasia mutated; Class III phosphatidylinositol 3 kinases; Hepatocytes; Lipoprotein

Indexed keywords

APOLIPOPROTEIN B48; APOLIPOPROTEIN E; ATM PROTEIN; CHLOROQUINE; CHOLESTEROL; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; ENDOCYTOSIS; ENDOSOME; ENZYME ACTIVITY; GENE MUTATION; HETEROZYGOSITY; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION;

ALLELES; ANIMALS; APOLIPOPROTEIN B-48; APOLIPOPROTEINS E; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CHLOROQUINE; ENDOCYTOSIS; ENDOSOMES; HEPATOCYTES; HETEROZYGOTE; MICE; MICE, KNOCKOUT; PHOSPHATIDYLINOSITOL 3-KINASES;

EID: 84893776100     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1566     Document Type: Article

References (30)

1. Frappart PO and McKinnon PJ: Ataxia-telangiectasia and related diseases. Neuromolecular Med 8: 495-511, 2006.
2. Lavin MF: ATM: The product of the gene mutated in ataxia-telangiectasia. Int J Biochem Cell Biol 31: 735-740, 1999.
3. Badalian LO and Kalinina LV: Lipid metabolism disorder in ataxia-telangiectasia. Zh Nevropatol Psikhiatr Im S S Korsakova 76: 665-669, 1976 (In Russian).
4. Su Y and Swift M: Mortality rates among carriers of ataxia-telangiectasia mutant alleles. Ann Intern Med 133: 770-778, 2000.
5. Schneider JG, Finck BN, Ren J, et al: ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell Metab 4: 377-389, 2006.
6. Mercer JR, Cheng KK, Figg N, et al: DNA damage links mitochondrial dysfunction to atherosclerosis and the metabolic syndrome. Circ Res 107: 1021-1031, 2010.
7. Wu D, Yang H, Xiang W, et al: Heterozygous mutation of ataxia-telangiectasia mutated gene aggravates hypercholesterolemia in apoE-deficient mice. J Lipid Res 46: 1380-1387, 2005.
8. Watters D, Kedar P, Spring K, et al: Localization of a portion of extranuclear ATM to peroxisomes. J Biol Chem 274: 34277-34282, 1999.
9. Kuljis RO, Chen G, Lee EY, Aguila MC and Xu Y: ATM immunolocalization in mouse neuronal endosomes: Implications for ataxia-telangiectasia. Brain Res 842: 351-358, 1999.
10. Barlow C, Ribaut-Barassin C, Zwingman TA, et al: ATM is a cytoplasmic protein in mouse brain required to prevent lysosomal accumulation. Proc Natl Acad Sci USA 97: 871-876, 2000.
11. Lim DS, Kirsch DG, Canman CE, et al: ATM binds to beta-adaptin in cytoplasmic vesicles. Proc Natl Acad Sci USA 95: 10146-10151, 1998.
12. Engelman JA, Luo J and Cantley LC: The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7: 606-619, 2006.
13. Backer JM: Phosphoinositide 3-kinases and the regulation of vesicular trafficking. Mol Cell Biol Res Commun 3: 193-204, 2000.
14. Hunyady L, Baukal AJ, Gaborik Z, et al: Differential PI 3-kinase dependence of early and late phases of recycling of the internalized AT1 angiotensin receptor. J Cell Biol 157: 1211-1222, 2002.
15. Lemmon MA: Phosphoinositide recognition domains. Traffic 4: 201-213, 2003.
16. Gillooly DJ, Morrow IC, Lindsay M, et al: Localization of phosphatidylinositol 3-phosphate in yeast and mammalian cells. EMBO J 19: 4577-4588, 2000.
17. Kutateladze TG: Phosphatidylinositol 3-phosphate recognition and membrane docking by the FYVE domain. Biochim Biophys Acta 1761: 868-877, 2006.
18. Choi JH, Hong WP, Kim MJ, Kim JH, Ryu SH and Suh PG: Sorting nexin 16 regulates EGF receptor trafficking by phospha-tidylinositol-3-phosphate interaction with the Phox domain. J Cell Sci 117: 4209-4218, 2004.
19. Shetty S, Eckhardt ER, Post SR and van der Westhuyzen DR: Phosphatidylinositol-3-kinase regulates scavenger receptor class B type I subcellular localization and selective lipid uptake in hepatocytes. Arterioscler Thromb Vasc Biol 26: 2125-2131, 2006.
20. Kzhyshkowska J, Gratchev A, Brundiers H, Mamidi S, Krusell L and Goerdt S: Phosphatidylinositide 3-kinase activity is required for stabilin-1-mediated endosomal transport of acLDL. Immunobiology 210: 161-173, 2005.
21. Lavin MF, Khanna KK, Beamish H, Spring K, Watters D and Shiloh Y: Relationship of the ataxia-telangiectasia protein ATM to phosphoinositide 3-kinase. Trends Biochem Sci 20: 382-383, 1995.
22. Khanna KK, Yan J, Watters D, et al: Defective signaling through the B cell antigen receptor in Epstein-Barr virus-transformed ataxia-telangiectasia cells. J Biol Chem 272: 9489-9495, 1997.
23. Chen A, Guo Z, Zhou L and Yang H: Hepatic endosome protein profiling in apolipoprotein E deficient mice expressing apolipoprotein B48 but not B100. J Bioanal Biomed 2: 100-106, 2010.
24. Gamble W, Vaughan M, Kruth HS and Avigan J: Procedure for determination of free and total cholesterol in micro-or nanogram amounts suitable for studies with cultured cells. J Lipid Res 19: 1068-1070, 1978.
25. Martins IJ, Hone E, Chi C, Seydel U, Martins RN and Redgrave TG: Relative roles of LDLr and LRP in the metabolism of chylomicron remnants in genetically manipulated mice. J Lipid Res 41: 205-213, 2000.
26. Hui DY, Innerarity TL, Milne RW, Marcel YL and Mahley RW: Binding of chylomicron remnants and beta-very low density lipoproteins to hepatic and extrahepatic lipoprotein receptors. A process independent of apolipoprotein B48. J Biol Chem 259: 15060-15068, 1984.
27. Corvera S: Phosphatidylinositol 3-kinase and the control of endosome dynamics: New players defined by structural motifs. Traffic 2: 859-866, 2001.
28. Clague MJ, Urbé S and de Lartigue J: Phosphoinositides and the endocytic pathway. Exp Cell Res 315: 1627-1631, 2009.
29. Bakkenist CJ and Kastan MB: DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421: 499-506, 2003.
30. Magoori K, Kang MJ, Ito MR, et al: Severe hypercholesterolemia, impaired fat tolerance, and advanced atherosclerosis in mice lacking both low density lipoprotein receptor-related protein 5 and apolipoprotein E. J Biol Chem 278: 11331-11336, 2003.